MacroGenics, Inc.
MGNX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $106,232 | $76,395 | $79,966 | $203,519 |
| - Cash | $80,129 | $130,686 | $145,570 | $182,840 |
| + Debt | $37,009 | $107,507 | $37,466 | $37,461 |
| Enterprise Value | $63,112 | $53,216 | -$28,138 | $58,140 |
| Revenue | $72,839 | $22,241 | $13,192 | $17,730 |
| % Growth | 227.5% | 68.6% | -25.6% | – |
| Gross Profit | $59,461 | $13,335 | $7,792 | $12,240 |
| % Margin | 81.6% | 60% | 59.1% | 69% |
| EBITDA | $21,953 | -$33,437 | -$39,174 | -$12,448 |
| % Margin | 30.1% | -150.3% | -297% | -70.2% |
| Net Income | $16,822 | -$36,251 | -$41,036 | -$15,421 |
| % Margin | 23.1% | -163% | -311.1% | -87% |
| EPS Diluted | 0.27 | -0.57 | -0.65 | -0.25 |
| % Growth | 147.4% | 12.3% | -160% | – |
| Operating Cash Flow | -$30,186 | -$46,985 | -$46,890 | -$38,407 |
| Capital Expenditures | -$426 | -$715 | -$529 | -$620 |
| Free Cash Flow | -$30,612 | -$47,700 | -$47,419 | -$39,027 |